Sam Chun Dang Pharm Co Ltd (000250)

Currency in KRW
199,100
+100(+0.05%)
Delayed Data·
000250 Scorecard
Full Analysis
Stock generally trades with high price volatility
000250 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
197,700201,000
52 wk Range
88,200245,000
Key Statistics
Bid/Ask
199,000.00 / 199,100.00
Prev. Close
199,000
Open
199,600
Day's Range
197,700-201,000
52 wk Range
88,200-245,000
Volume
31.66K
Average Volume (3m)
239.31K
1-Year Change
49.89%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
000250 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Sam Chun Dang Pharm Co Ltd Company Profile

Sam Chun Dang Pharm. Co., Ltd engages in the manufacturing and sale of pharmaceutical products in South Korea. It provides ethical and over the counter products in various therapeutic areas comprising ophthalmology, cardiovascular, endocrinology, antibacterial, anti-fungal, antiviral, respiratory, anti-inflammatory, antihistamine, and musculoskeletal products, as well as vitamins and gastro intestine products. The company is also involved in exporting activities. Sam Chun Dang Pharm. Co., Ltd was founded in 1943 and is headquartered in Seoul, South Korea.

Employees
419

Compare 000250 to Peers and Sector

Metrics to compare
000250
Peers
Sector
Relationship
P/E Ratio
−306.8x14.3x−0.6x
PEG Ratio
1.90−0.210.00
Price/Book
17.9x0.9x2.6x
Price / LTM Sales
21.5x0.6x3.3x
Upside (Analyst Target)
-30.4%37.7%
Fair Value Upside
Unlock28.1%3.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -648.65%
Dividend Yield
0.10%
Industry Median 0.87%
Annualised payout
200.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Aug 29, 2025
EPS / Forecast
-143.44 / --
Revenue / Forecast
56.90B / --
EPS Revisions
Last 90 days

000250 Income Statement

People Also Watch

180,000
009150
+0.73%
61,000
034020
+0.16%
105,100
000270
+0.19%
942,000
012450
-0.95%
347,500
373220
+1.16%

FAQ

What Stock Exchange Does Sam Chun Dang Pharm Trade On?

Sam Chun Dang Pharm is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Sam Chun Dang Pharm?

The stock symbol for Sam Chun Dang Pharm is "000250."

What Is the Sam Chun Dang Pharm Market Cap?

As of today, Sam Chun Dang Pharm market cap is 4.63T.

What Is Sam Chun Dang Pharm's Earnings Per Share (TTM)?

The Sam Chun Dang Pharm EPS (TTM) is -648.65.

When Is the Next Sam Chun Dang Pharm Earnings Date?

Sam Chun Dang Pharm will release its next earnings report on 12 Nov 2025.

From a Technical Analysis Perspective, Is 000250 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sam Chun Dang Pharm Stock Split?

Sam Chun Dang Pharm has split 0 times.

How Many Employees Does Sam Chun Dang Pharm Have?

Sam Chun Dang Pharm has 419 employees.

What is the current trading status of Sam Chun Dang Pharm (000250)?

As of 09 Sept 2025, Sam Chun Dang Pharm (000250) is trading at a price of 199,100, with a previous close of 199,000.00. The stock has fluctuated within a day range of 197,700 to 201,000, while its 52-week range spans from 88,200 to 245,000.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.